Suzhou Basecare Medical Corporation Limited (HKG:2170)
2.020
-0.030 (-1.46%)
Jan 21, 2026, 3:42 PM HKT
HKG:2170 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Net Income | -238.59 | -237.03 | -191.69 | -122.66 | -143.65 | -877.05 | Upgrade |
Depreciation & Amortization | 42.74 | 35.66 | 19.53 | 8.39 | 5.59 | 6.72 | Upgrade |
Other Amortization | 0.02 | 0.02 | 0.04 | - | - | - | Upgrade |
Loss (Gain) From Sale of Assets | 0.66 | 0.66 | 0.18 | -8.7 | -0 | 0.6 | Upgrade |
Loss (Gain) From Sale of Investments | -2.9 | -2.9 | 2.4 | -3.4 | - | -0.12 | Upgrade |
Loss (Gain) on Equity Investments | - | - | - | - | - | -0.25 | Upgrade |
Stock-Based Compensation | - | - | - | - | 7.91 | - | Upgrade |
Other Operating Activities | -11.83 | -27.85 | -55.65 | -89.96 | 11.27 | 831.88 | Upgrade |
Change in Accounts Receivable | 26.12 | 26.12 | 2.14 | -15.07 | -46.89 | -45.35 | Upgrade |
Change in Inventory | 3.94 | 3.94 | -21.15 | -14.74 | -24.1 | 4.13 | Upgrade |
Change in Accounts Payable | -52.42 | -52.42 | -22.39 | 30.18 | 7.75 | 18.98 | Upgrade |
Change in Unearned Revenue | 24.82 | 24.82 | -1.57 | 2 | - | - | Upgrade |
Change in Other Net Operating Assets | -0.14 | -0.14 | 0.92 | 15.73 | -15.73 | - | Upgrade |
Operating Cash Flow | -207.59 | -229.12 | -267.23 | -188.77 | -197.85 | -64.29 | Upgrade |
Capital Expenditures | -89.76 | -93.3 | -104.21 | -128.45 | -28.9 | -8.09 | Upgrade |
Sale of Property, Plant & Equipment | 4.72 | 1.54 | 0.88 | 0.08 | 0.36 | 0.12 | Upgrade |
Cash Acquisitions | - | - | -257.89 | -32.51 | -42.48 | - | Upgrade |
Divestitures | - | - | -3.24 | 53.6 | - | 15.15 | Upgrade |
Sale (Purchase) of Intangibles | - | - | - | -0.06 | - | - | Upgrade |
Investment in Securities | 70 | -111.88 | - | - | - | 30.93 | Upgrade |
Other Investing Activities | 13.41 | 22.44 | 39.64 | 18.65 | 14.42 | -4.58 | Upgrade |
Investing Cash Flow | -1.63 | -181.19 | -324.81 | -88.7 | -56.6 | 33.53 | Upgrade |
Long-Term Debt Issued | - | 90.14 | 196.74 | 49.75 | 43.65 | 30 | Upgrade |
Total Debt Issued | 51.49 | 90.14 | 196.74 | 49.75 | 43.65 | 30 | Upgrade |
Long-Term Debt Repaid | - | -44.85 | -4.79 | -23.15 | -32.63 | -31.7 | Upgrade |
Total Debt Repaid | -49.19 | -44.85 | -4.79 | -23.15 | -32.63 | -31.7 | Upgrade |
Net Debt Issued (Repaid) | 2.31 | 45.3 | 191.95 | 26.6 | 11.01 | -1.7 | Upgrade |
Issuance of Common Stock | - | - | - | - | 1,678 | 226.67 | Upgrade |
Other Financing Activities | -12.8 | -11.52 | -1.4 | -3.09 | -93.69 | -17.5 | Upgrade |
Financing Cash Flow | -10.49 | 33.78 | 190.55 | 23.51 | 1,596 | 207.47 | Upgrade |
Foreign Exchange Rate Adjustments | -1.23 | 6.06 | 12.57 | 62.91 | -10.31 | -8.55 | Upgrade |
Net Cash Flow | -220.94 | -370.47 | -388.93 | -191.05 | 1,331 | 168.17 | Upgrade |
Free Cash Flow | -297.35 | -322.41 | -371.44 | -317.22 | -226.75 | -72.38 | Upgrade |
Free Cash Flow Margin | -107.85% | -107.79% | -178.60% | -225.14% | -211.33% | -89.23% | Upgrade |
Free Cash Flow Per Share | -1.09 | -1.18 | -1.36 | -1.16 | -0.85 | -0.42 | Upgrade |
Cash Interest Paid | 0.39 | 0.47 | 0.24 | 0.19 | 0.24 | 0.1 | Upgrade |
Cash Income Tax Paid | 0.08 | -0.02 | 3.26 | - | - | - | Upgrade |
Levered Free Cash Flow | -246.81 | -267.63 | -244.92 | -195.9 | -160.63 | -78.64 | Upgrade |
Unlevered Free Cash Flow | -238.77 | -261.77 | -243.28 | -195.59 | -159.84 | -77.72 | Upgrade |
Change in Working Capital | 2.31 | 2.31 | -42.05 | 18.1 | -78.96 | -22.24 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.